Voice of the Global Clinical Research Industry

The Association of Clinical Research represents companies at the forefront of global clinical research. ACRO members are committed to innovation in clinical development and thought leadership on research policy and COVID-19.

Slide Image

Responses and Resources for COVID-19

Click here for ACRO’s latest statements on the COVID-19 pandemic.


Read about ACRO’s initiatives, COVID-19 efforts, and more.

Member Innovation Hub

Take a look at how our members are innovating in top focus areas.

US Regulatory Policy

Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »

European Advocacy

ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »

CRO Forum

ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »

Clinical Research Roundtables

In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »

Addressing Industry Pain Points

We help create a predictable, enabling business environment. ACRO’s proactive agenda is focused on policy outcomes that advance specific operational interests of ACRO members. More »

Data Protection & Privacy

ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »


Get ACRO’s free quarterly newsletter to stay informed about our work and the industry.

Join ACRO and Add Your Voice

We help create a global regulatory and business environment
where ACRO members succeed

News and Comments

NewsPress Releases

ACRO Members Heed the UK Government’s Call for Volunteers in Response to the COVID-19 Pandemic

May 6, 2020

May 6, 2020 – (Washington, DC) – In an effort to fight the global COVID-19 pandemic, over 150 employees from clinical research…

Read More

2020 Officers and New Member Announcement

December 17, 2019

Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Alistair…

Read More

ACRO hosts Congressional Briefing on clinical research advancements

October 24, 2019

On Wednesday, October 23, 2019, ACRO hosted a Congressional Briefing on Capitol Hill. With the help of the Congressional Research & Development…

Read More

A Consistent Approach to Risk Based Quality Management: Collaboration is Key

October 24, 2019

Developing, executing and overseeing clinical trials is a complex process. Yet it is essential to gain reliable evidence from clinical trials to…

Read More

New ACRO Report Quantifies Benefits of RBM for Quality Reviews

October 17, 2019

A new report based on a survey of ACRO members reveals that Risk-Based Monitoring (RBM) makes clinical trial quality review more efficient…

Read More

Advancing the Adoption of Risk-Based Monitoring Strategies in Clinical Trials

August 16, 2019

On July 17, 2019, under cooperative agreement with the FDA, the Duke-Margolis Center for Health Policy (Duke Margolis) held a public workshop. The event, titled Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations, aimed to identify opportunities to improve Risk Based Monitoring (RBM) implementation and solicit stakeholder input on the challenges, barriers, and enablers that impact the successful adoption of RBM.

ACRO Members